Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement - 1st Quarter

9 Feb 2021 07:00

RNS Number : 3742O
Income & Growth VCT (The) PLC
09 February 2021
 

LEI: 213800FPC15FNM74YD92

 

The Income & Growth VCT PLC

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2020

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 31 December 2020. The statement also includes relevant financial information between the end of the quarter and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 31 December 2020

At 30 September 2020

 

Net assets attributable to shareholders

 

£93,681,750

£83,133,430

Shares in issue

118,325,511

118,661,711

Net asset value (NAV) per share

 

79.17p

70.06p

Cumulative dividends paid to date per share since inception

131.50p

131.50p

Total return per share since inception (NAV basis)

210.67p

201.56p

 

The NAV per share has increased by 9.11 pence in the quarter (an increase of 13% upon the opening NAV per share). This is principally due to a rise in unrealised portfolio valuations as well as gains on realisations (further details below).

 

SHARE BUY-BACKS

 

On 16 December 2020, the Company bought back 336,200 of its own ordinary shares at a price of 66.56 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

INVESTMENT ACTIVITY

 

New investments during the period

On 22 December 2020, the Company made a new investment of £0.47 million into Northern Bloc Ice Cream Limited, a dairy-free ice cream manufacturer.

 

On 30 December 2020, the Company made a new investment of £1.16 million into Connect Childcare Group Limited, a provider of nursery management software.

 

Realisations during the period

On 27 November 2020, the Company sold its investment in Vectair Holdings Limited, generating cash proceeds of £1.10 million. Over the fifteen years this investment was held, it generated cash proceeds of £1.79 million compared to an original investment cost of £0.22 million, which is a multiple on cost of 8.3x and an IRR of 22.2%

 

On 29 December 2020, the Company sold its investment in Bourn Bioscience Limited, generating cash proceeds of £2.14 million. Over the nearly seven years this investment was held, it generated cash proceeds of £2.64 million compared to an original investment cost of £1.61 million, which is a multiple on cost of 1.6x and an IRR of 8.5%.

 

 

Loan repayments and further proceeds during the period

On 16 October 2020, the Company received loan repayment proceeds of £0.21 million from Vian Marketing Limited (trading as Red Paddle Co.).

 

On 14 December 2020, the Company received deferred consideration of £0.09 million from Redline Worldwide Limited, an investment realised in a previous year.

 

Further investments after the period end

On 7 January 2021, the Company made a further investment of £0.36 million into Parsley Box Limited, a supplier of home-delivered ambient meals for the elderly.

 

On 5 February 2021, the Company made a further investment of £0.15 million into Bleach London Holdings Limited, a hair colourants brand.

 

Loan repayments and further proceeds after the period end

After the period end, on 26 January 2021, the Company received a loan repayment of £0.06 million in respect of BG Training Limited.

 

Also after the period end, on 27 January 2021, the Company received further proceeds of £0.14 million in respect of Blaze Signs Holdings Limited, an investment realised in a previous year.

 

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the quarter and to the date of this announcement.

 

 

For further information, please contact:

Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFUWVNRAKUURAR
Date   Source Headline
18th Jun 202511:15 amRNSChange of Name
9th Jun 202512:30 pmRNSRealisation of investment in Rota Geek Limited
2nd Jun 20257:00 amRNSRealisation of investment in My Tutorweb Limited
1st May 20257:00 amRNSTotal Voting Rights
11th Apr 20253:49 pmRNSDirector/PDMR Shareholding
11th Apr 20253:12 pmRNSIssue of Equity and Total Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20257:00 amRNSTransaction in own shares and Total Voting Rights
6th Mar 20251:23 pmRNSInterim Management Statement
5th Mar 20256:05 pmRNSResult of AGM
5th Mar 20255:17 pmRNSDividend Declaration
3rd Mar 20252:30 pmRNSTotal Voting Rights and Capital
26th Feb 20256:10 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSTotal Voting Rights
21st Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20257:00 amRNSAnnual Financial Report
2nd Dec 20247:00 amRNSTotal Voting Rights and Capital
29th Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
18th Oct 20243:10 pmRNSDirector/PDMR Shareholding
18th Oct 20242:58 pmRNSIssue of Equity and Total Voting Rights
17th Oct 20244:26 pmRNSOFFER FOR SUBSCRIPTION - UPDATE
2nd Oct 20247:05 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
26th Sep 20242:23 pmRNSTransaction in Own Shares and Total Voting Rights
18th Sep 202410:00 amRNSOffer for Subscription – Update
12th Sep 20245:31 pmRNSInterim Management Statement
11th Sep 20244:33 pmRNSDividend Declaration
2nd Sep 20243:15 pmRNSOffers for Subscription – Open for Applications
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights and Capital
26th Jul 20243:00 pmRNSDirector/PDMR Shareholding
26th Jul 20242:00 pmRNSGENERAL MEETINGS AND MERGER RESULTS
24th Jul 20244:15 pmRNSNet Asset Value(s)
18th Jul 20241:30 pmRNSMERGER UPDATE AND GENERAL MEETINGS
4th Jul 20247:00 amRNSTransaction in Own shares and Total Voting Rights
1st Jul 20249:35 amRNSTotal Voting Rights
27th Jun 20248:00 amRNSDirector Declaration
18th Jun 20245:54 pmRNSPROPOSED MERGER AND OFFERS
12th Jun 20244:08 pmRNSHalf-year Report
12th Jun 202410:39 amRNSIssue of Equity and Total Voting Rights
10th Jun 20244:00 pmRNSMerger Proposals/Intention To Launch Joint Offers
7th Jun 202411:05 amRNSDirector/PDMR Shareholding
7th Jun 202410:29 amRNSIssue of Equity and Total Voting Rights
3rd Jun 20242:29 pmRNSNet Asset Value at 31 March 2024
3rd Jun 20247:00 amRNSTotal Voting Rights and Capital
9th May 202411:29 amRNSDividend Declaration - Replacement
9th May 20247:00 amRNSDividend Declaration
1st May 20247:00 amRNSTotal Voting Rights and Capital
2nd Apr 20249:32 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.